Portfolio company
Astrego
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops automated microfluidic systems for rapid antibiotic susceptibility testing to support clinicians in diagnosing and treating bacterial infections at point-of-care settings.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Resistell
This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.
Astratus
Astratus develops rapid microfluidic diagnostic tests and prototype instrument readers for antimicrobial susceptibility testing in human and veterinary clinical laboratories.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
ShanX Medtech
The company develops rapid antimicrobial susceptibility testing diagnostics for healthcare providers to identify effective antibiotic treatments for bacterial infections in approximately one hour.
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
iFAST
iFAST Diagnostics develops rapid antimicrobial susceptibility testing systems for hospital laboratories to identify effective antibiotics for treating bacterial infections.
Resistell AG
Resistell AG develops rapid antibiotic susceptibility testing platforms using nanomotion technology for healthcare providers and clinical researchers to improve treatment of bloodstream infections.
